India’s pharma exports stay resilient amid global headwinds, near $29 billion mark

Indian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues despite global market volatility. Formulations, biologicals, vaccines, and Ayush products are leading the surge. The sector is poised for significant expansion by 2030. India remains a vital global supplier of affordable medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/G42yv0f
via IFTTT